ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 423,67
0,20%
Dow Jones
42 418,77
0,29%
DAX
20 271,33
0,67%
Brent Oil
79,53
-0,93%
Bitcoin
96 674,96
2,29%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PureTech Health PLC (PRTC)

  7. PureTech Health PLC (PRTC) Actualités

PRTC

PureTech Health (PRTC)

PureTech Health PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRTC
DateHeureSourceTitreSymboleSociété
09/01/202513h00Business WirePureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML)NASDAQ:PRTCPureTech Health PLC
08/01/202513h00Business WirePureTech to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
06/01/202508h00Business WirePureTech Appoints UBS as UK Corporate BrokerNASDAQ:PRTCPureTech Health PLC
16/12/202408h00Business WirePureTech’s Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b TrialNASDAQ:PRTCPureTech Health PLC
11/12/202413h05Business WirePureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024NASDAQ:PRTCPureTech Health PLC
09/12/202408h00Business WirePureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual MeetingNASDAQ:PRTCPureTech Health PLC
20/11/202413h05Business WirePureTech Founded Entity Seaport Therapeutics Adds Sandi Peterson to its Board of DirectorsNASDAQ:PRTCPureTech Health PLC
05/11/202413h05Business WirePureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial OfficerNASDAQ:PRTCPureTech Health PLC
30/10/202412h00Business WirePureTech to Present at Two Upcoming Investor ConferencesNASDAQ:PRTCPureTech Health PLC
21/10/202408h00Business WirePureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing RoundNASDAQ:PRTCPureTech Health PLC
09/10/202408h00Business WirePureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual MeetingNASDAQ:PRTCPureTech Health PLC
01/10/202413h00Business WirePureTech to Present at CHEST 2024 Annual MeetingNASDAQ:PRTCPureTech Health PLC
27/09/202408h00Business WirePureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in AdultsNASDAQ:PRTCPureTech Health PLC
06/09/202408h00Business WirePureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted TherapiesNASDAQ:PRTCPureTech Health PLC
28/08/202422h31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
28/08/202408h01Business WirePureTech Health plc – Half-Year ReportNASDAQ:PRTCPureTech Health PLC
22/08/202408h00Business WirePureTech Appoints Michele Holcomb, PhD, to Board of DirectorsNASDAQ:PRTCPureTech Health PLC
21/08/202408h00Business WirePureTech Health: Notice of Half-Yearly ResultsNASDAQ:PRTCPureTech Health PLC
13/08/202413h05Business WirePureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of DirectorsNASDAQ:PRTCPureTech Health PLC
23/07/202414h26Business WirePureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of CommercialNASDAQ:PRTCPureTech Health PLC
24/06/202418h00Business WirePureTech Health: Completion of Tender Offer & Total Voting RightsNASDAQ:PRTCPureTech Health PLC
24/06/202408h00Business WirePureTech Health: Results of the Tender OfferNASDAQ:PRTCPureTech Health PLC
20/06/202408h00Business WirePureTech Announces Change of Board RoleNASDAQ:PRTCPureTech Health PLC
18/06/202413h05Business WirePureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management TeamNASDAQ:PRTCPureTech Health PLC
13/06/202419h15Business WirePureTech Health: Results of Annual General MeetingNASDAQ:PRTCPureTech Health PLC
06/06/202422h39Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:PRTCPureTech Health PLC
06/06/202418h38Business WirePureTech Health: Result of General MeetingNASDAQ:PRTCPureTech Health PLC
30/05/202414h05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:PRTCPureTech Health PLC
29/05/202414h09Business WirePureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health CompanyNASDAQ:PRTCPureTech Health PLC
23/05/202413h00Business WirePureTech to Present at the Jefferies Global Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
 Showing the most relevant articles for your search:NASDAQ:PRTC

Dernières Valeurs Consultées

EU
ORA
Orange
COIN
SOLUSD
Solana
COIN
AVAXUSD
Avalanche
EU
SGO
Cie de SaintGobain
EU
BEL20
Bel 20
EU
AI
Air Liquide
NASDAQ
AMZN
Amazon.com
NYSE
JPM
JP Morgan Chase
EU
AF
Air FranceKLM
EU
RNO
Renault
EU
GLE
Societe Generale
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés